Taltz Psa Observational Study
Research payments
$1,192,832
Through program year 2025, $1,192,832 in research payments was reported against Taltz Psa Observational Study, across 55 payments, paid by Eli Lilly and Company.
- Paid by
- Eli Lilly and Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $45,037 | 11 |
| 2024 | Research | $1,147,796 | 44 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Arnaldo Torres Saint Petersburg, FL Named on 2 payments
- Frederick Murphy Duncansville, PA Named on 2 payments
- Kurt Oelke Milwaukee, WI Named on 2 payments
- Alan Alberts Tamarac, FL Named on 2 payments
- Andrew Sharobeem Avondale, AZ Named on 2 payments
- Rakesh Patel Salisbury, NC Named on 2 payments
- Areena Swarup Mesa, AZ Named on 2 payments
- Dan La Tujunga, CA Named on 1 payment
- Nehad Soloman Avondale, AZ Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.